VESIcare

Product NDC: 51248-150
11-digit product format: 512480150
Labeler code: 51248
Product ID: 51248-150_5de8c6b0-8a05-4b69-ae10-ffc7ddd286e3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: solifenacin succinate
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Astellas Pharma US, Inc.
Application: NDA021518
Marketing category: NDA
Marketing start: 2005-01-05
Marketing end: 2026-08-31
Substance: SOLIFENACIN SUCCINATE
Active strength: 5 mg/1
Pharmacologic classes: Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag: No
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021518-001	VESICARE	SOLIFENACIN SUCCINATE	5MG	TABLET / ORAL		RLD	2004-11-19
N021518-002	VESICARE	SOLIFENACIN SUCCINATE	10MG	TABLET / ORAL		RLD	2004-11-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021518-001	VESICARE	5MG	TABLET / ORAL		RLD	2004-11-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021518-002	VESICARE	10MG	TABLET / ORAL		RLD	2004-11-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021518-001	VESICARE	5MG	TABLET / ORAL	AB	RLD	2004-11-19	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021518-002	VESICARE	10MG	TABLET / ORAL	AB	RLD, RS	2004-11-19	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021518-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021518-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021518-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021518-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021518-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021518-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021518-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021518-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021518-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021518-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021518-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021518-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021518-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021518-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021518-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021518-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021518-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021518-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021518-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021518-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021518-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021518-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021518-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021518-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021518-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021518-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021518-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021518-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021518-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021518-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021518-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021518-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021518-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021518-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021518-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021518-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021518-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021518-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021518-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021518-002	AB	1	`87673890dc5c…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021518-001	6017927*PED	2019-05-19	Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021518-002	6017927*PED	2019-05-19	Pediatric extension	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N021518-001	6017927*PED	2019-05-19	Pediatric extension	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021518-002	6017927*PED	2019-05-19	Pediatric extension	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021518-001	6017927*PED	2019-05-19	Pediatric extension	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021518-002	6017927*PED	2019-05-19	Pediatric extension	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021518-001	6017927*PED	2019-05-19	Pediatric extension	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021518-002	6017927*PED	2019-05-19	Pediatric extension	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: VESIcare

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
SOLIFENACIN SUCCINATE	5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
KKA5DLD701	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
477367	Internal RxNorm lookup
477372	Internal RxNorm lookup
539815	Internal RxNorm lookup
539817	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9acee910-cdb2-4052-b8b3-c26aff1c8716	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
efc179d5-753a-8dcd-90d4-5676a1c31ce3	Product name	7	20250423
7a525cfb-2fd5-4f2e-bf22-13a2c0cea1dd	Product name	1	20201030

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51248-150-01	VESIcare	30 in 1 BOTTLE	TABLET, FILM COATED	30		30

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51248-150-01	EA - Each	51248-150	2f11fd9d-9b07-4d5f-9c34-0ff260c11c85	1	2012-07-24
51248-150-03	EA - Each	51248-150	24d1307c-b722-4a1c-8197-8b9b098b7ddd	1	2012-07-24
51248-150-52	EA - Each	51248-150	4bc68dce-d55b-438b-81b5-32b0313f0e40	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SOLIFENACIN SUCCINATE	ACTIVE INGREDIENT	KKA5DLD701	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [ASTELLAS PHARMA TECHNOLOGIES, INC.]	20
SOLIFENACIN	ACTIVE MOIETY	A8910SQJ1U	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [ASTELLAS PHARMA TECHNOLOGIES, INC.]	20
SOLIFENACIN SUCCINATE	ACTIVE INGREDIENT	KKA5DLD701	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [CARDINAL HEALTH]	8
SOLIFENACIN	ACTIVE MOIETY	A8910SQJ1U	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [CARDINAL HEALTH]	8
SOLIFENACIN SUCCINATE	ACTIVE INGREDIENT	KKA5DLD701	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [CARDINAL HEALTH]	2
SOLIFENACIN SUCCINATE	ACTIVE INGREDIENT	KKA5DLD701	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
SOLIFENACIN	ACTIVE MOIETY	A8910SQJ1U	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [CARDINAL HEALTH]	2
SOLIFENACIN	ACTIVE MOIETY	A8910SQJ1U	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51248-150	VESICARE (SOLIFENACIN SUCCINATE) TABLET, FILM COATED [ASTELLAS PHARMA US, INC.]	29	Current NDC, Legacy NDC, 1 package rows	20230511_9acee910-cdb2-4052-b8b3-c26aff1c8716.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VESIcare	SOLIFENACIN SUCCINATE	Astellas Pharma US, Inc.	9acee910-cdb2-4052-b8b3-c26aff1c8716	2022-10-31	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021518 application number: NDA021518 ndc (product): 51248-150

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
KKA5DLD701	SOLIFENACIN SUCCINATE	242478-38-2	SOLIFENACIN SUCCINATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
477372	solifenacin succinate 10 MG Oral Tablet	PSN	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
477367	solifenacin succinate 5 MG Oral Tablet	PSN	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
539815	VESICARE 10 MG Oral Tablet	PSN	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
539817	VESICARE 5 MG Oral Tablet	PSN	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
539815	solifenacin succinate 10 MG Oral Tablet [Vesicare]	SBD	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
539817	solifenacin succinate 5 MG Oral Tablet [Vesicare]	SBD	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
477372	solifenacin succinate 10 MG Oral Tablet	SCD	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
477367	solifenacin succinate 5 MG Oral Tablet	SCD	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
539815	VESIcare 10 MG Oral Tablet	SY	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
539817	VESIcare 5 MG Oral Tablet	SY	9acee910-cdb2-4052-b8b3-c26aff1c8716	30
477372	solifenacin succinate 10 MG Oral Tablet	PSN	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
477367	solifenacin succinate 5 MG Oral Tablet	PSN	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
477367	solifenacin succinate 5 MG Oral Tablet	PSN	100678f1-313a-4e99-ae77-319c610a830f	2
539815	VESICARE 10 MG Oral Tablet	PSN	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
539817	VESICARE 5 MG Oral Tablet	PSN	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
539817	VESICARE 5 MG Oral Tablet	PSN	100678f1-313a-4e99-ae77-319c610a830f	2
539815	solifenacin succinate 10 MG Oral Tablet [Vesicare]	SBD	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
539817	solifenacin succinate 5 MG Oral Tablet [Vesicare]	SBD	100678f1-313a-4e99-ae77-319c610a830f	2
539817	solifenacin succinate 5 MG Oral Tablet [Vesicare]	SBD	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
477372	solifenacin succinate 10 MG Oral Tablet	SCD	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
477367	solifenacin succinate 5 MG Oral Tablet	SCD	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
477367	solifenacin succinate 5 MG Oral Tablet	SCD	100678f1-313a-4e99-ae77-319c610a830f	2
539815	VESIcare 10 MG Oral Tablet	SY	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
539817	VESIcare 5 MG Oral Tablet	SY	e433dc68-6b2a-4c48-beae-4ec946f1ff1e	2
539817	VESIcare 5 MG Oral Tablet	SY	100678f1-313a-4e99-ae77-319c610a830f	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
51248-150-01	51248015001	30 TABLET, FILM COATED in 1 BOTTLE (51248-150-01)	2005-01-05	2026-08-31	No	No	Current
51248-150-03	51248015003	90 TABLET, FILM COATED in 1 BOTTLE (51248-150-03)	2005-01-05	0000-00-00	No	No	Current
51248-150-52	51248015052	100 TABLET, FILM COATED in 1 BLISTER PACK (51248-150-52)	2005-01-05	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
VESIcare	Astellas Pharma US, Inc.	2022-10-31	HUMAN PRESCRIPTION DRUG LABEL	30
VESIcare	REMEDYREPACK INC.	2019-05-22	HUMAN PRESCRIPTION DRUG LABEL	1
VESIcare	Cardinal Health	2019-04-17	HUMAN PRESCRIPTION DRUG LABEL	12
VESIcare	Carilion Materials Management	2017-12-28	HUMAN PRESCRIPTION DRUG LABEL	2
VESIcare	A-S Medication Solutions	2017-11-08	HUMAN PRESCRIPTION DRUG LABEL	3
VESIcare	Cardinal Health	2015-04-29	HUMAN PRESCRIPTION DRUG LABEL	2
VESIcare	Physicians Total Care, Inc.	2012-03-06	HUMAN PRESCRIPTION DRUG LABEL	2